Orange Book product · Generic (ANDA)
MIDOSTAURIN
MIDOSTAURIN
Generic (ANDA)ANDA 216015TE ABRX LUPIN
At a glance
May 10, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 10, 2024
2 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
MIDOSTAURIN
Strength
25MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 216015
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MIDOSTAURIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
